{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T01:02:05Z","timestamp":1794013325997,"version":"4.8.0"},"reference-count":128,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["gimjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Genetics in Medicine"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.gim.2023.101054","type":"journal-article","created":{"date-parts":[[2024,2,13]],"date-time":"2024-02-13T07:58:50Z","timestamp":1707811130000},"page":"101054","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Section E6.1\u20136.6 of the American College of Medical Genetics and Genomics (ACMG) Technical Laboratory Standards: Cytogenomic studies of acquired chromosomal abnormalities in neoplastic blood, bone marrow, and lymph nodes"],"prefix":"10.1016","volume":"26","author":[{"given":"Yassmine","family":"Akkari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda B.","family":"Baughn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annette","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ender","family":"Karaca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gordana","family":"Raca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fady M.","family":"Mikhail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.gim.2023.101054_bib1","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/gim.2016.50","article-title":"Section E6.1-6.4 of the ACMG technical standards and guidelines: chromosome studies of neoplastic blood and bone marrow-acquired chromosomal abnormalities","volume":"18","author":"Mikhail","year":"2016","journal-title":"Genet Med"},{"key":"10.1016\/j.gim.2023.101054_bib2","unstructured":"Swerdlow SH, Campo E, Harris NJ, et al. eds. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. WHO Classification of Tumours. rev 4th ed. Vol. 2. International Agency for Research on Cancer; 2017. https:\/\/www.iarc.who.int\/"},{"issue":"7","key":"10.1016\/j.gim.2023.101054_bib3","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1038\/s41375-022-01613-1","article-title":"The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic\/Dendritic Neoplasms","volume":"36","author":"Khoury","year":"2022","journal-title":"Leukemia"},{"issue":"7","key":"10.1016\/j.gim.2023.101054_bib4","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1038\/s41375-022-01620-2","article-title":"The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms","volume":"36","author":"Alaggio","year":"2022","journal-title":"Leukemia"},{"issue":"11","key":"10.1016\/j.gim.2023.101054_bib5","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1182\/blood.2022015850","article-title":"International Consensus Classification of myeloid neoplasms and acute leukemias: integrating morphologic, clinical, and genomic data","volume":"140","author":"Arber","year":"2022","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.gim.2023.101054_bib6","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1182\/blood.2022015851","article-title":"The International Consensus Classification of mature lymphoid neoplasms: a report from the Clinical Advisory Committee","volume":"140","author":"Campo","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.gim.2023.101054_bib7","series-title":"Mitelman Database of Chromosome Aberrations and Gene Fusions in Cancer","year":"2023"},{"key":"10.1016\/j.gim.2023.101054_bib8","series-title":"The AGT Cytogenetics Laboratory Manual","author":"Arsham","year":"2017"},{"issue":"2","key":"10.1016\/j.gim.2023.101054_bib9","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/j.1365-2141.2004.05017.x","article-title":"Impact of pre-analytical handling on bone marrow mRNA gene expression","volume":"126","author":"Breit","year":"2004","journal-title":"Br J Haematol"},{"issue":"1","key":"10.1016\/j.gim.2023.101054_bib10","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1046\/j.1365-2141.1998.00951.x","article-title":"IL-4 improves the detection of cytogenetic abnormalities in multiple myeloma and increases the proportion of clonally abnormal metaphases","volume":"103","author":"Hern\u00e1ndez","year":"1998","journal-title":"Br J Haematol"},{"issue":"11","key":"10.1016\/j.gim.2023.101054_bib11","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1002\/gcc.21982","article-title":"High detection rate of clinically relevant genomic abnormalities in plasma cells enriched from patients with multiple myeloma","volume":"51","author":"Stevens-Kroef","year":"2012","journal-title":"Genes Chromosomes Cancer"},{"issue":"5","key":"10.1016\/j.gim.2023.101054_bib12","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1111\/j.1751-553X.2012.01433.x","article-title":"Application of an immune-magnetic cell sorting method for CD138-positive plasma cells in FISH analysis of multiple myeloma","volume":"34","author":"Shin","year":"2012","journal-title":"Int J Lab Hematol"},{"key":"10.1016\/j.gim.2023.101054_bib13","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.cancergen.2018.07.002","article-title":"Assessing genome-wide copy number aberrations and copy-neutral loss-of-heterozygosity as best practice: an evidence-based review from the Cancer Genomics Consortium working group for plasma cell disorders","volume":"228-229","author":"Pugh","year":"2018","journal-title":"Cancer Genet"},{"issue":"3","key":"10.1016\/j.gim.2023.101054_bib14","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1158\/1055-9965.EPI-07-2649","article-title":"Effect of tissue shipping on plasma cell isolation, viability, and RNA integrity in the context of a centralized good laboratory practice-certified tissue banking facility","volume":"17","author":"Ahmann","year":"2008","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"5","key":"10.1016\/j.gim.2023.101054_bib15","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1309\/AJCPF7NFLW8UAJEP","article-title":"Detection of genomic abnormalities in multiple myeloma: the application of FISH analysis in combination with various plasma cell enrichment techniques","volume":"136","author":"Hartmann","year":"2011","journal-title":"Am J Clin Pathol"},{"issue":"3","key":"10.1016\/j.gim.2023.101054_bib16","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1002\/cyto.b.21619","article-title":"Evaluation of CD229 as a new alternative plasma cell gating marker in the flow cytometric immunophenotyping of monoclonal gammopathies","volume":"94","author":"Tembhare","year":"2018","journal-title":"Cytometry B Clin Cytom"},{"issue":"4","key":"10.1016\/j.gim.2023.101054_bib17","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1002\/cyto.b.21961","article-title":"CD319 (SLAMF7) an alternative marker for detecting plasma cells in the presence of daratumumab or elotuzumab","volume":"100","author":"Soh","year":"2021","journal-title":"Cytometry B Clin Cytom"},{"issue":"2","key":"10.1016\/j.gim.2023.101054_bib18","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.cancergencyto.2010.07.128","article-title":"Stimulation of chronic lymphocytic leukemia cells with CpG oligodeoxynucleotide gives consistent karyotypic results among laboratories: a CLL Research Consortium (CRC) Study","volume":"203","author":"Heerema","year":"2010","journal-title":"Cancer Genet Cytogenet"},{"issue":"5","key":"10.1016\/j.gim.2023.101054_bib19","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1309\/AJCP7G4VMYZJQVFI","article-title":"Improved detection rate of cytogenetic abnormalities in chronic lymphocytic leukemia and other mature B-cell neoplasms with use of CpG-oligonucleotide DSP30 and interleukin 2 stimulation","volume":"139","author":"Shi","year":"2013","journal-title":"Am J Clin Pathol"},{"issue":"3","key":"10.1016\/j.gim.2023.101054_bib20","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.jmoldx.2019.01.007","article-title":"Personalized chimerism test that uses selection of short tandem repeat or quantitative PCR depending on patient\u2019s chimerism status","volume":"21","author":"Tyler","year":"2019","journal-title":"J\u00a0Mol Diagn"},{"issue":"5","key":"10.1016\/j.gim.2023.101054_bib21","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1111\/ijlh.13073","article-title":"Digital droplet PCR-based chimerism analysis for monitoring of hematopoietic engraftment after allogeneic stem cell transplantation","volume":"41","author":"Mika","year":"2019","journal-title":"Int J Lab Hematol"},{"issue":"11","key":"10.1016\/j.gim.2023.101054_bib22","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/j.humimm.2021.07.013","article-title":"A\u00a0practical guide to chimerism analysis: review of the literature and testing practices worldwide","volume":"82","author":"Blouin","year":"2021","journal-title":"Hum Immunol"},{"key":"10.1016\/j.gim.2023.101054_bib23","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/978-1-61779-074-4_14","article-title":"Fluorescence in situ hybridization on formalin-fixed, paraffin-embedded tissue sections","volume":"730","author":"Zordan","year":"2011","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.gim.2023.101054_bib24","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.cancergen.2018.07.005","volume":"228-229","author":"Xu","year":"2018","journal-title":"Cancer Genet"},{"key":"10.1016\/j.gim.2023.101054_bib25","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.cancergen.2018.07.003","volume":"228-229","author":"Kanagal-Shamanna","year":"2018","journal-title":"Cancer Genet"},{"key":"10.1016\/j.gim.2023.101054_bib26","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.cancergen.2018.07.004","article-title":"Assessing copy number aberrations and copy-neutral loss-of-heterozygosity across the genome as best practice: an evidence-based review from the Cancer Genomics Consortium (CGC) working group for chronic lymphocytic leukemia","volume":"228-229","author":"Chun","year":"2018","journal-title":"Cancer Genet"},{"key":"10.1016\/j.gim.2023.101054_bib27","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.cancergen.2020.03.001","article-title":"Evidence-based review of genomic aberrations in B-lymphoblastic leukemia\/lymphoma: report from the Cancer Genomics Consortium working group for lymphoblastic leukemia","volume":"243","author":"Akkari","year":"2020","journal-title":"Cancer Genet"},{"issue":"9","key":"10.1016\/j.gim.2023.101054_bib28","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1038\/s41436-019-0545-7","volume":"21","author":"Mikhail","year":"2019","journal-title":"Genet Med"},{"issue":"6","key":"10.1016\/j.gim.2023.101054_bib29","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1309\/AJCPP6LVMQG4LNCK","article-title":"Conventional karyotyping and fluorescence in situ hybridization: an effective utilization strategy in diagnostic adult acute myeloid leukemia","volume":"143","author":"He","year":"2015","journal-title":"Am J Clin Pathol"},{"issue":"5","key":"10.1016\/j.gim.2023.101054_bib30","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1093\/ajcp\/aqy002","article-title":"Limited utility of fluorescence in situ hybridization for recurrent abnormalities in acute myeloid leukemia at diagnosis and follow-up","volume":"149","author":"Wheeler","year":"2018","journal-title":"Am J Clin Pathol"},{"issue":"4","key":"10.1016\/j.gim.2023.101054_bib31","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1182\/blood-2016-08-733196","article-title":"Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel","volume":"129","author":"D\u00f6hner","year":"2017","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.gim.2023.101054_bib32","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1182\/blood.2022016867","article-title":"Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN","volume":"140","author":"D\u00f6hner","year":"2022","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.gim.2023.101054_bib33","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/leu.2016.267","article-title":"NUP98 is rearranged in 3.8% of pediatric AML forming a clinical and molecular homogenous group with a poor prognosis","volume":"31","author":"Struski","year":"2017","journal-title":"Leukemia"},{"issue":"1","key":"10.1016\/j.gim.2023.101054_bib34","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/leu.2012.230","article-title":"A\u00a0rare but specific subset of adult AML patients can be defined by the cytogenetically cryptic NUP98-NSD1 fusion gene","volume":"27","author":"Fasan","year":"2013","journal-title":"Leukemia"},{"issue":"7","key":"10.1016\/j.gim.2023.101054_bib35","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1002\/gcc.22064","article-title":"NUP98-NSD1 gene fusion and its related gene expression signature are strongly associated with a poor prognosis in pediatric acute myeloid leukemia","volume":"52","author":"Shiba","year":"2013","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.gim.2023.101054_bib36","doi-asserted-by":"crossref","DOI":"10.1002\/gcc.22887","article-title":"MLLT10 rearranged acute leukemia: incidence, prognosis, and possible therapeutic strategies","author":"Forgione","year":"20205912709","journal-title":"Genes Chromosomes Cancer"},{"issue":"8","key":"10.1016\/j.gim.2023.101054_bib37","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1002\/gcc.22741","article-title":"Acute leukemias harboring KMT2A\/MLLT10 fusion: a 10-year experience from a single genomics laboratory","volume":"58","author":"Peterson","year":"2019","journal-title":"Genes Chromosomes Cancer"},{"issue":"17","key":"10.1016\/j.gim.2023.101054_bib38","doi-asserted-by":"crossref","first-page":"2900","DOI":"10.1002\/cncr.29475","article-title":"Prognostic significance of acquired copy-neutral loss of heterozygosity in acute myeloid leukemia","volume":"121","author":"Gronseth","year":"2015","journal-title":"Cancer"},{"issue":"20","key":"10.1016\/j.gim.2023.101054_bib39","doi-asserted-by":"crossref","first-page":"9152","DOI":"10.1158\/0008-5472.CAN-05-2017","article-title":"Association between acquired uniparental disomy and homozygous gene mutation in acute myeloid leukemias","volume":"65","author":"Fitzgibbon","year":"2005","journal-title":"Cancer Res"},{"issue":"11","key":"10.1016\/j.gim.2023.101054_bib40","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1182\/blood-2010-05-286492","article-title":"t(X;14)(p22;q32)\/t(Y;14)(p11;q32) CRLF2-IGH translocations from human B-lineage ALLs involve CpG-type breaks at CRLF2, but CRLF2\/P2RY8 intrachromosomal deletions do not","volume":"116","author":"Tsai","year":"2010","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.gim.2023.101054_bib41","first-page":"773","article-title":"14q32 rearrangements deregulating BCL11B mark a distinct subgroup of T-lymphoid and myeloid immature acute leukemia","volume":"138","author":"Di Giacomo","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.gim.2023.101054_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.leukres.2019.106177","article-title":"High resolution chromosomal microarray analysis (CMA) enhances the genetic profile of pediatric B-cell acute lymphoblastic leukemia patients","volume":"83","author":"Mitrakos","year":"2019","journal-title":"Leuk Res"},{"issue":"4","key":"10.1016\/j.gim.2023.101054_bib43","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1007\/s00277-020-03953-3","article-title":"Implementation of RNA sequencing and array CGH in the diagnostic workflow of the AIEOP-BFM ALL 2017 trial on acute lymphoblastic leukemia","volume":"99","author":"Schieck","year":"2020","journal-title":"Ann Hematol"},{"issue":"7137","key":"10.1016\/j.gim.2023.101054_bib44","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1038\/nature05690","article-title":"Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia","volume":"446","author":"Mullighan","year":"2007","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.gim.2023.101054_bib45","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.jmoldx.2016.03.004","article-title":"Genome-wide single-nucleotide polymorphism array analysis improves prognostication of acute lymphoblastic leukemia\/lymphoma","volume":"18","author":"Wang","year":"2016","journal-title":"J\u00a0Mol Diagn"},{"issue":"12","key":"10.1016\/j.gim.2023.101054_bib46","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1200\/JCO.2017.74.3617","article-title":"IKZF1plus defines a new minimal residual disease-dependent very-poor prognostic profile in pediatric B-cell precursor acute lymphoblastic leukemia","volume":"36","author":"Stanulla","year":"2018","journal-title":"J\u00a0Clin Oncol"},{"issue":"12","key":"10.1016\/j.gim.2023.101054_bib47","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1038\/ng.3691","article-title":"Deregulation of DUX4 and ERG in acute lymphoblastic leukemia","volume":"48","author":"Zhang","year":"2016","journal-title":"Nat Genet"},{"issue":"12","key":"10.1016\/j.gim.2023.101054_bib48","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1002\/gcc.23084","article-title":"Characterization of unusual iAMP21 B-lymphoblastic leukemia (iAMP21-ALL) from the Mayo Clinic and Children\u2019s Oncology Group","volume":"61","author":"Koleilat","year":"2022","journal-title":"Genes Chromosomes Cancer"},{"issue":"9","key":"10.1016\/j.gim.2023.101054_bib49","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1182\/blood-2016-10-706465","article-title":"The genetics and molecular biology of T-ALL","volume":"129","author":"Girardi","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.gim.2023.101054_bib50","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cancergen.2018.12.002","article-title":"Multidisciplinary analysis of pediatric T-ALL: 9q34 gene fusions","volume":"231-232","author":"Papenhausen","year":"2019","journal-title":"Cancer Genet"},{"issue":"7","key":"10.1016\/j.gim.2023.101054_bib51","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.leukres.2012.03.013","article-title":"Will a peripheral blood (PB) sample yield the same diagnostic and prognostic cytogenetic data as the concomitant bone marrow (BM) in myelodysplasia?","volume":"36","author":"Cherry","year":"2012","journal-title":"Leuk Res"},{"issue":"3","key":"10.1016\/j.gim.2023.101054_bib52","doi-asserted-by":"crossref","first-page":"601","DOI":"10.3109\/10428194.2013.801470","article-title":"Limited utility of fluorescence in situ hybridization for common abnormalities of myelodysplastic syndrome at first presentation and follow-up of myeloid neoplasms","volume":"55","author":"Seegmiller","year":"2014","journal-title":"Leuk Lymphoma"},{"issue":"12","key":"10.1016\/j.gim.2023.101054_bib53","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1182\/blood-2012-03-420489","article-title":"Revised international prognostic scoring system for myelodysplastic syndromes","volume":"120","author":"Greenberg","year":"2012","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.gim.2023.101054_bib54","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1038\/s41591-020-1008-z","article-title":"Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes","volume":"26","author":"Bernard","year":"2020","journal-title":"Nat Med"},{"issue":"2","key":"10.1016\/j.gim.2023.101054_bib55","doi-asserted-by":"crossref","first-page":"555","DOI":"10.3324\/haematol.2019.240689","article-title":"Genomic alterations in patients with somatic loss of the Y chromosome as the sole cytogenetic finding in bone marrow cells","volume":"106","author":"Ouseph","year":"2021","journal-title":"Haematologica"},{"issue":"11","key":"10.1016\/j.gim.2023.101054_bib56","doi-asserted-by":"crossref","first-page":"E420","DOI":"10.1002\/ajh.26325","article-title":"Myelodysplastic syndromes with no somatic mutations detected by next-generation sequencing display similar features to myelodysplastic syndromes with detectable mutations","volume":"96","author":"Wang","year":"2021","journal-title":"Am J Hematol"},{"issue":"7714","key":"10.1016\/j.gim.2023.101054_bib57","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/s41586-018-0321-x","article-title":"Insights into clonal haematopoiesis from 8,342 mosaic chromosomal alterations","volume":"559","author":"Loh","year":"2018","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.gim.2023.101054_bib58","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1080\/10428190802492415","article-title":"Influence of additional cytogenetic abnormalities on the response and survival in late chronic phase chronic myeloid leukemia patients treated with imatinib: long-term results","volume":"50","author":"Palandri","year":"2009","journal-title":"Leuk Lymphoma"},{"issue":"26","key":"10.1016\/j.gim.2023.101054_bib59","doi-asserted-by":"crossref","first-page":"6760","DOI":"10.1182\/blood-2011-08-373902","article-title":"Impact of additional cytogenetic aberrations at diagnosis on prognosis of CML: long-term observation of 1151 patients from the randomized CML Study IV","volume":"118","author":"Fabarius","year":"2011","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.gim.2023.101054_bib60","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1007\/s00277-013-1695-3","article-title":"Hematologic malignancies with PCM1-JAK2 gene fusion share characteristics with myeloid and lymphoid neoplasms with eosinophilia and abnormalities of PDGFRA, PDGFRB, and FGFR1","volume":"92","author":"Patterer","year":"2013","journal-title":"Ann Hematol"},{"issue":"9","key":"10.1016\/j.gim.2023.101054_bib61","doi-asserted-by":"crossref","first-page":"e148","DOI":"10.3324\/haematol.2014.105452","article-title":"PDGFRB-rearranged T-lymphoblastic leukemia\/lymphoma occurring with myeloid neoplasms: the missing link supporting a stem cell origin","volume":"99","author":"Ondrejka","year":"2014","journal-title":"Haematologica"},{"issue":"8","key":"10.1016\/j.gim.2023.101054_bib62","doi-asserted-by":"crossref","first-page":"e348","DOI":"10.3324\/haematol.2017.187302","article-title":"Molecular genetic characterization of myeloid\/lymphoid neoplasms associated with eosinophilia and rearrangement of PDGFRA, PDGFRB, FGFR1 or PCM1-JAK2","volume":"103","author":"Baer","year":"2018","journal-title":"Haematologica"},{"issue":"13","key":"10.1016\/j.gim.2023.101054_bib63","doi-asserted-by":"crossref","first-page":"3136","DOI":"10.1182\/bloodadvances.2020002308","article-title":"Targeted FGFR inhibition results in a durable remission in an FGFR1-driven myeloid neoplasm with eosinophilia","volume":"4","author":"Kasbekar","year":"2020","journal-title":"Blood Adv"},{"issue":"2","key":"10.1016\/j.gim.2023.101054_bib64","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1093\/ajcp\/aqaa208","article-title":"Myeloid\/lymphoid neoplasms associated with eosinophilia and rearrangements of PDGFRA, PDGFRB, or FGFR1 or with PCM1-JAK2","volume":"155","author":"Pozdnyakova","year":"2021","journal-title":"Am J Clin Pathol"},{"issue":"19","key":"10.1016\/j.gim.2023.101054_bib65","doi-asserted-by":"crossref","first-page":"4924","DOI":"10.1182\/bloodadvances.2019001282","article-title":"Diagnosis and treatment of mixed phenotype (T-myeloid\/lymphoid) acute leukemia with novel ETV6-FGFR2 rearrangement","volume":"4","author":"Carll","year":"2020","journal-title":"Blood Adv"},{"issue":"4","key":"10.1016\/j.gim.2023.101054_bib66","doi-asserted-by":"crossref","first-page":"e412","DOI":"10.1038\/bcj.2016.11","article-title":"Myeloproliferative neoplasm with eosinophilia and T-lymphoblastic lymphoma with ETV6-LYN gene fusion","volume":"6","author":"Telford","year":"2016","journal-title":"Blood Cancer J"},{"key":"10.1016\/j.gim.2023.101054_bib67","doi-asserted-by":"crossref","DOI":"10.1016\/j.leukres.2020.106460","article-title":"Myeloid\/lymphoid neoplasms with eosinophilia and FLT3 rearrangement","volume":"99","author":"Shao","year":"2020","journal-title":"Leuk Res"},{"issue":"9","key":"10.1016\/j.gim.2023.101054_bib68","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1038\/s41379-021-00817-7","article-title":"Myeloid\/lymphoid neoplasms with FLT3 rearrangement","volume":"34","author":"Tang","year":"2021","journal-title":"Mod Pathol"},{"issue":"10","key":"10.1016\/j.gim.2023.101054_bib69","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1182\/bloodadvances.2019001275","article-title":"Metaphase cytogenetics and plasma cell proliferation index for risk stratification in newly diagnosed multiple myeloma","volume":"4","author":"Mellors","year":"2020","journal-title":"Blood Adv"},{"issue":"4","key":"10.1016\/j.gim.2023.101054_bib70","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/s41408-021-00474-8","article-title":"Chromosome 1q21 abnormalities in multiple myeloma","volume":"11","author":"Schmidt","year":"2021","journal-title":"Blood Cancer J"},{"issue":"19","key":"10.1016\/j.gim.2023.101054_bib71","doi-asserted-by":"crossref","first-page":"6033","DOI":"10.1158\/1078-0432.CCR-08-0347","article-title":"Deletions of CDKN2C in multiple myeloma: biological and clinical implications","volume":"14","author":"Leone","year":"2008","journal-title":"Clin Cancer Res"},{"issue":"1","key":"10.1016\/j.gim.2023.101054_bib72","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/s41375-018-0196-8","article-title":"A\u00a0high-risk, double-hit, group of newly diagnosed myeloma identified by genomic analysis","volume":"33","author":"Walker","year":"2019","journal-title":"Leukemia"},{"issue":"45","key":"10.1016\/j.gim.2023.101054_bib73","doi-asserted-by":"crossref","first-page":"78259","DOI":"10.18632\/oncotarget.20875","article-title":"Hyperhaploid karyotypes in multiple myeloma","volume":"8","author":"Sawyer","year":"2017","journal-title":"Oncotarget"},{"issue":"3","key":"10.1016\/j.gim.2023.101054_bib74","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/s41408-019-0182-z","article-title":"Hyperhaploid plasma cell myeloma characterized by poor outcome and monosomy 17 with frequently co-occurring TP53 mutations","volume":"9","author":"Peterson","year":"2019","journal-title":"Blood Cancer J"},{"issue":"7","key":"10.1016\/j.gim.2023.101054_bib75","doi-asserted-by":"crossref","first-page":"732","DOI":"10.18632\/oncotarget.26589","article-title":"Poor overall survival in hyperhaploid multiple myeloma is defined by double-hit bi-allelic inactivation of TP53","volume":"10","author":"Ashby","year":"2019","journal-title":"Oncotarget"},{"issue":"3","key":"10.1016\/j.gim.2023.101054_bib76","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1038\/leu.2016.253","article-title":"Hyperhaploidy is a novel high-risk cytogenetic subgroup in multiple myeloma","volume":"31","author":"Sawyer","year":"2017","journal-title":"Leukemia"},{"issue":"24","key":"10.1016\/j.gim.2023.101054_bib77","doi-asserted-by":"crossref","first-page":"6581","DOI":"10.1158\/1078-0432.CCR-20-2283","article-title":"Implications of MYC rearrangements in newly diagnosed multiple myeloma","volume":"26","author":"Abdallah","year":"2020","journal-title":"Clin Cancer Res"},{"issue":"1","key":"10.1016\/j.gim.2023.101054_bib78","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1038\/s41375-019-0543-4","article-title":"MYC dysregulation in the progression of multiple myeloma","volume":"34","author":"Misund","year":"2020","journal-title":"Leukemia"},{"issue":"7","key":"10.1016\/j.gim.2023.101054_bib79","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1002\/gcc.20668","article-title":"A\u00a0SNP microarray and FISH-based procedure to detect allelic imbalances in multiple myeloma: an integrated genomics approach reveals a wide gene dosage effect","volume":"48","author":"Agnelli","year":"2009","journal-title":"Genes Chromosomes Cancer"},{"issue":"27","key":"10.1016\/j.gim.2023.101054_bib80","doi-asserted-by":"crossref","first-page":"4585","DOI":"10.1200\/JCO.2008.20.6136","article-title":"Prognostic significance of copy-number alterations in multiple myeloma","volume":"27","author":"Avet-Loiseau","year":"2009","journal-title":"J\u00a0Clin Oncol"},{"issue":"15","key":"10.1016\/j.gim.2023.101054_bib81","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1182\/blood-2010-04-279596","article-title":"A\u00a0compendium of myeloma-associated chromosomal copy number abnormalities and their prognostic value","volume":"116","author":"Walker","year":"2010","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.gim.2023.101054_bib82","doi-asserted-by":"crossref","first-page":"5172","DOI":"10.1038\/s41467-021-25469-8","article-title":"Copy number signatures predict chromothripsis and clinical outcomes in newly diagnosed multiple myeloma","volume":"12","author":"Maclachlan","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.gim.2023.101054_bib83","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.semcdb.2021.04.014","article-title":"Chromothripsis as a pathogenic driver of multiple myeloma","volume":"123","author":"Maura","year":"2022","journal-title":"Semin Cell Dev Biol"},{"issue":"3","key":"10.1016\/j.gim.2023.101054_bib84","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.blre.2011.02.002","article-title":"Importance of genetics in chronic lymphocytic leukemia","volume":"25","author":"Zenz","year":"2011","journal-title":"Blood Rev"},{"issue":"9","key":"10.1016\/j.gim.2023.101054_bib85","doi-asserted-by":"crossref","first-page":"3152","DOI":"10.1182\/blood-2006-02-005322","article-title":"Immunostimulatory oligonucleotide-induced metaphase cytogenetics detect chromosomal aberrations in 80% of CLL patients: a study of 132 CLL cases with correlation to FISH, IgVH status, and CD38 expression","volume":"108","author":"Dicker","year":"2006","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.gim.2023.101054_bib86","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1002\/ajh.24452","article-title":"FISHing in the dark: how the combination of FISH and conventional karyotyping improves the diagnostic yield in CpG-stimulated chronic lymphocytic leukemia","volume":"91","author":"Dubuc","year":"2016","journal-title":"Am J Hematol"},{"issue":"2","key":"10.1016\/j.gim.2023.101054_bib87","doi-asserted-by":"crossref","first-page":"184","DOI":"10.2353\/jmoldx.2010.090118","article-title":"Array-based karyotyping for prognostic assessment in chronic lymphocytic leukemia: performance comparison of Affymetrix 10K2.0, 250K nsp, and SNP6.0 arrays","volume":"12","author":"Hagenkord","year":"2010","journal-title":"J\u00a0Mol Diagn"},{"issue":"3","key":"10.1016\/j.gim.2023.101054_bib88","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1111\/j.1751-553X.2010.01284.x","article-title":"Comparison of array comparative genomic hybridization (aCGH) to FISH and cytogenetics in prognostic evaluation of chronic lymphocytic leukemia","volume":"33","author":"O\u2019Malley","year":"2011","journal-title":"Int J Lab Hematol"},{"issue":"4","key":"10.1016\/j.gim.2023.101054_bib89","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s11912-020-0898-8","article-title":"Burkitt and Burkitt-like lymphomas: a systematic review","volume":"22","author":"Saleh","year":"2020","journal-title":"Curr Oncol Rep"},{"issue":"8","key":"10.1016\/j.gim.2023.101054_bib90","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1182\/blood-2013-06-507996","article-title":"A\u00a0recurrent 11q aberration pattern characterizes a subset of MYC-negative high-grade B-cell lymphomas resembling Burkitt lymphoma","volume":"123","author":"Salaverria","year":"2014","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.gim.2023.101054_bib91","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.blre.2016.09.004","article-title":"High grade B-cell lymphoma with rearrangements of MYC and BCL2 and\/or BCL6: double hit and triple hit lymphomas and double expressing lymphoma","volume":"31","author":"Rosenthal","year":"2017","journal-title":"Blood Rev"},{"issue":"3","key":"10.1016\/j.gim.2023.101054_bib92","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1097\/PAP.0b013e3182169948","article-title":"MYC and aggressive B-cell lymphomas","volume":"18","author":"Slack","year":"2011","journal-title":"Adv Anat Pathol"},{"issue":"6","key":"10.1016\/j.gim.2023.101054_bib93","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1038\/leu.2011.378","article-title":"BCL2 mutations in diffuse large B-cell lymphoma","volume":"26","author":"Schuetz","year":"2012","journal-title":"Leukemia"},{"issue":"4","key":"10.1016\/j.gim.2023.101054_bib94","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0095020","article-title":"C-MYC aberrations as prognostic factors in diffuse large B-cell lymphoma: a meta-analysis of epidemiological studies","volume":"9","author":"Zhou","year":"2014","journal-title":"PLOS ONE"},{"issue":"9","key":"10.1016\/j.gim.2023.101054_bib95","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.medcli.2021.03.041","article-title":"Follicular lymphoma: an update on diagnosis, prognosis, and management","volume":"157","author":"Mozas","year":"2021","journal-title":"Med Clin (Barc)"},{"issue":"9","key":"10.1016\/j.gim.2023.101054_bib96","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1182\/blood.V83.9.2423.2423","article-title":"LAZ3 rearrangements in non-Hodgkin\u2019s lymphoma: correlation with histology, immunophenotype, karyotype, and clinical outcome in 217 patients","volume":"83","author":"Bastard","year":"1994","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.gim.2023.101054_bib97","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/gcc.20246","article-title":"BCL6 alternative translocation breakpoint cluster region associated with follicular lymphoma grade 3B","volume":"44","author":"Bosga-Bouwer","year":"2005","journal-title":"Genes Chromosomes Cancer"},{"issue":"8","key":"10.1016\/j.gim.2023.101054_bib98","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1182\/blood-2015-12-682591","article-title":"Pediatric-type nodal follicular lymphoma: a biologically distinct lymphoma with frequent MAPK pathway mutations","volume":"128","author":"Louissaint","year":"2016","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.gim.2023.101054_bib99","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s00428-018-2384-3","article-title":"Concomitant 1p36 deletion and TNFRSF14 mutations in primary cutaneous follicle center lymphoma frequently expressing high levels of EZH2 protein","volume":"473","author":"G\u00e1ng\u00f3","year":"2018","journal-title":"Virchows Arch"},{"issue":"9","key":"10.1016\/j.gim.2023.101054_bib100","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1007\/s00277-004-0879-2","article-title":"Coexistence of BCL1\/CCND1 and CMYC aberrations in blastoid mantle cell lymphoma: a rare finding associated with very poor outcome","volume":"83","author":"Michaux","year":"2004","journal-title":"Ann Hematol"},{"issue":"3","key":"10.1016\/j.gim.2023.101054_bib101","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1182\/blood-2006-01-0015","article-title":"A\u00a0chromosomal translocation in cyclin D1-negative\/cyclin D2-positive mantle cell lymphoma fuses the CCND2 gene to the IGK locus","volume":"108","author":"Gesk","year":"2006","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.gim.2023.101054_bib102","doi-asserted-by":"crossref","first-page":"5683","DOI":"10.1182\/blood-2007-10-118794","article-title":"Translocations targeting CCND2, CCND3, and MYCN do occur in t(11;14)-negative mantle cell lymphomas","volume":"111","author":"Wlodarska","year":"2008","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.gim.2023.101054_bib103","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.hoc.2020.05.002","article-title":"Molecular pathogenesis of mantle cell lymphoma","volume":"34","author":"Navarro","year":"2020","journal-title":"Hematol Oncol Clin North Am"},{"issue":"5","key":"10.1016\/j.gim.2023.101054_bib104","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1016\/S0002-9440(10)65411-9","article-title":"7q31-32 allelic loss is a frequent finding in splenic marginal zone lymphoma","volume":"154","author":"Mateo","year":"1999","journal-title":"Am J Pathol"},{"issue":"1","key":"10.1016\/j.gim.2023.101054_bib105","first-page":"71","article-title":"Splenic marginal zone B-cell lymphomas: two cytogenetic subtypes, one with gain of 3q and the other with loss of 7q","volume":"86","author":"Sol\u00e9","year":"2001","journal-title":"Haematologica"},{"issue":"9","key":"10.1016\/j.gim.2023.101054_bib106","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1182\/blood-2010-02-267476","article-title":"Cytogenetic aberrations and their prognostic value in a series of 330 splenic marginal zone B-cell lymphomas: a multicenter study of the splenic B-cell Lymphoma Group","volume":"116","author":"Salido","year":"2010","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.gim.2023.101054_bib107","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1182\/blood-2010-01-264275","article-title":"Genome-wide DNA profiling of marginal zone lymphomas identifies subtype-specific lesions with an impact on the clinical outcome","volume":"117","author":"Rinaldi","year":"2011","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.gim.2023.101054_bib108","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1023\/A:1008357314157","article-title":"The product of the t(11;18), an API2-MLT fusion, is an almost exclusive finding in marginal zone cell lymphoma of extranodal MALT-type","volume":"11","author":"Maes","year":"2000","journal-title":"Ann Oncol"},{"issue":"6","key":"10.1016\/j.gim.2023.101054_bib109","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1182\/blood-2002-09-2963","article-title":"T(14;18)(q32;q21) involving IGH and MALT1 is a frequent chromosomal aberration in MALT lymphoma","volume":"101","author":"Streubel","year":"2003","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.gim.2023.101054_bib110","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1365-2141.2006.05969.x","article-title":"Distinct comparative genomic hybridisation profiles in gastric mucosa-associated lymphoid tissue lymphomas with and without t(11;18)(q21;q21)","volume":"133","author":"Zhou","year":"2006","journal-title":"Br J Haematol"},{"issue":"7","key":"10.1016\/j.gim.2023.101054_bib111","doi-asserted-by":"crossref","first-page":"921","DOI":"10.3324\/haematol.10191","article-title":"The pattern of genomic gains in salivary gland MALT lymphomas","volume":"92","author":"Zhou","year":"2007","journal-title":"Haematologica"},{"issue":"6","key":"10.1016\/j.gim.2023.101054_bib112","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/j.humpath.2006.12.019","article-title":"Anaplastic lymphoma kinase-positive diffuse large B-cell lymphoma with a complex karyotype and cryptic 3\u2032 ALK gene insertion to chromosome 4 q22-24","volume":"38","author":"Stachurski","year":"2007","journal-title":"Hum Pathol"},{"issue":"2","key":"10.1016\/j.gim.2023.101054_bib113","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1097\/PAI.0b013e31818629a8","article-title":"ALK-positive diffuse large B-cell lymphoma with the t(2;17)(p23;q23)","volume":"17","author":"Zhang","year":"2009","journal-title":"Appl Immunohistochem Mol Morphol"},{"issue":"12","key":"10.1016\/j.gim.2023.101054_bib114","doi-asserted-by":"crossref","first-page":"5496","DOI":"10.1182\/blood-2008-01-134270","article-title":"ALK- anaplastic large-cell lymphoma is clinically and immunophenotypically different from both ALK+ ALCL and peripheral T-cell lymphoma, not otherwise specified: report from the International Peripheral T-Cell Lymphoma Project","volume":"111","author":"Savage","year":"2008","journal-title":"Blood"},{"issue":"18","key":"10.1016\/j.gim.2023.101054_bib115","doi-asserted-by":"crossref","first-page":"3418","DOI":"10.1182\/blood-2010-02-270785","article-title":"Treatment and prognosis of mature T-cell and NK-cell lymphoma: an analysis of patients with T-cell lymphoma treated in studies of the German High-Grade Non-Hodgkin Lymphoma Study Group","volume":"116","author":"Schmitz","year":"2010","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.gim.2023.101054_bib116","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1038\/leu.2014.347","article-title":"A\u00a0novel patient-derived tumorgraft model with TRAF1-ALK anaplastic large-cell lymphoma translocation","volume":"29","author":"Abate","year":"2015","journal-title":"Leukemia"},{"issue":"3","key":"10.1016\/j.gim.2023.101054_bib117","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1182\/blood-2010-08-303305","article-title":"Discovery of recurrent t(6;7)(p25.3;q32.3) translocations in ALK-negative anaplastic large cell lymphomas by massively parallel genomic sequencing","volume":"117","author":"Feldman","year":"2011","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.gim.2023.101054_bib118","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1182\/blood-2012-03-419937","article-title":"Genome-wide analysis reveals recurrent structural abnormalities of TP63 and other p53-related genes in peripheral T-cell lymphomas","volume":"120","author":"Vasmatzis","year":"2012","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.gim.2023.101054_bib119","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1182\/blood-2014-04-571091","article-title":"ALK-negative anaplastic large cell lymphoma is a genetically heterogeneous disease with widely disparate clinical outcomes","volume":"124","author":"Parrilla Castellar","year":"2014","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.gim.2023.101054_bib120","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.ccell.2015.03.006","article-title":"Convergent mutations and kinase fusions lead to oncogenic STAT3 activation in anaplastic large cell lymphoma","volume":"27","author":"Crescenzo","year":"2015","journal-title":"Cancer Cell"},{"issue":"9","key":"10.1016\/j.gim.2023.101054_bib121","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1182\/blood-2016-03-707141","article-title":"Integrated mate-pair and RNA sequencing identifies novel, targetable gene fusions in peripheral T-cell lymphoma","volume":"128","author":"Boddicker","year":"2016","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.gim.2023.101054_bib122","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1038\/ng.3415","article-title":"Integrated molecular analysis of adult T cell leukemia\/lymphoma","volume":"47","author":"Kataoka","year":"2015","journal-title":"Nat Genet"},{"issue":"6","key":"10.1016\/j.gim.2023.101054_bib123","doi-asserted-by":"crossref","first-page":"757","DOI":"10.3324\/haematol.2015.139253","article-title":"Frequent CTLA4-CD28 gene fusion in diverse types of T-cell lymphoma","volume":"101","author":"Yoo","year":"2016","journal-title":"Haematologica"},{"issue":"14","key":"10.1016\/j.gim.2023.101054_bib124","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1182\/blood.2019000402","article-title":"Consensus criteria for diagnosis, staging, and treatment response assessment of T-cell prolymphocytic leukemia","volume":"134","author":"Staber","year":"2019","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.gim.2023.101054_bib125","article-title":"T-cell prolymphocytic leukemia: an overview of current and future approaches","volume":"13","author":"Colon Ramos","year":"2021","journal-title":"Cureus"},{"issue":"18","key":"10.1016\/j.gim.2023.101054_bib126","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1182\/blood.2019004118","article-title":"Hepatosplenic T-cell lymphoma: a rare but challenging entity","volume":"136","author":"Pro","year":"2020","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.gim.2023.101054_bib127","doi-asserted-by":"crossref","first-page":"e248","DOI":"10.3324\/haematol.2018.207290","article-title":"False-negative rates for MYC fluorescence in situ hybridization probes in B-cell neoplasms","volume":"104","author":"King","year":"2019","journal-title":"Haematologica"},{"key":"10.1016\/j.gim.2023.101054_bib128","series-title":"ISCN 2020: an International System for Human Cytogenomic Nomenclature","year":"2020"}],"container-title":["Genetics in Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098360023010705?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098360023010705?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T17:52:27Z","timestamp":1762365147000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1098360023010705"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":128,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["S1098360023010705"],"URL":"https:\/\/doi.org\/10.1016\/j.gim.2023.101054","relation":{},"ISSN":["1098-3600"],"issn-type":[{"value":"1098-3600","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Section E6.1\u20136.6 of the American College of Medical Genetics and Genomics (ACMG) Technical Laboratory Standards: Cytogenomic studies of acquired chromosomal abnormalities in neoplastic blood, bone marrow, and lymph nodes","name":"articletitle","label":"Article Title"},{"value":"Genetics in Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gim.2023.101054","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 American College of Medical Genetics and Genomics. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101054"}}